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The shortage of liver grafts from deceased donors is universal. A deceased-donor whole liver 
from an otherwise healthy brain-dead donor is ideal for transplantation. This situation however 
is very uncommon since deceased donors often have comorbidities like hypertension, diabetes, 
or multiple injuries. On the occasion when a whole liver with excellent function is available for 
transplantation, splitting it into two grafts for two recipients is often done in order to maximize 
utilization. 
In the real world, reaching the best compromise of liver graft utilization is the desirable 
practice. What constitutes a marginal yet useable liver graft? Through a Cox regression model, 
Feng et al. [1] identified seven donor characteristics that independently predicted an increased 
risk of failure of a liver graft donated by a deceased donor. Among these, donation after cardiac 
death had a relative risk of 1.51 (95% confidence interval 1.19-1.91, p = 0.0006) for graft failure. 
Their study nevertheless did not include in the analysis cardiac arrest in donors who were 
successfully resuscitated. Cardiac arrest accounts for prolonged warm ischemic time (WIT) of 
various degrees in brain-dead-donor organs. As ischemia is central to liver cell death, duration 
of warm [2] and cold [1, 2] ischemia is significant in prevention of graft failure. While a high 
body mass index and hypernatremia of a donor are associated with a high risk of graft failure, 
critical care end points that reflect the normal hemodynamic, acid base, respiratory, endocrine 
and renal statuses of a donor are predictive of liver graft use for transplantation [3]. Thus 
meticulous brain-dead donor maintenance and resuscitation are important [4]. 
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Among all organs for transplantation, the liver has the strongest ability to recover from insults 
including ischemia. It is often the last organ to be given up for deceased donor organ 
transplantation. The remarkable regenerative and recovering abilities of the liver have been 
known for centuries, thus there is the myth of Prometheus [5]. The regenerative ability of the 
liver allows very major hepatectomy for cancer as well as the use of partial liver for 
transplantation. In the face of the shortage of deceased donor liver grafts, living donor liver 
transplantation (LDLT) becomes the attractive and realistic alternative to deceased donor liver 
transplantation (DDLT). In order to minimize the risk to living liver donors, a smallest workable 
size of liver is obtained for transplantation. With accumulation of experience, a living donor 
liver graft 30% the size of the recipient liver is acceptable, with a hospital mortality risk of 2% 
only [6]. Nevertheless, unlike that in DDLT, the cold ischemic time (CIT) in LDLT is often less 
than an hour. A WIT that is as short as possible is also aimed for. At centers employing 
temporary inflow control by the Pringle maneuver, warm ischemia occurs without significant 
graft damage [7]. 
 
In fact, temporary ischemia serves to precondition a liver graft for the hostile environment in 
recipients with portal hypertension and to counteract reperfusion injuries [8]. Hoyer et al. [9] 
compared recipients who received liver grafts from donors with cardiac arrest and recipients 
whose liver grafts were from donors without cardiac arrest. They found that the former group 
of recipients had lower peak serum aspartate aminotransferase (AST) levels. This observation 
was not new as another study earlier had a similar finding [10]. However, whether ischemic 
preconditioning of liver grafts has a protective effect is inconclusive [11]. Positive [12-15] and 
negative [16, 17] views both exist. In a French study of 165 DDLTs, 34 of the donors had a 
history of cardiac arrest. Their median AST level was higher (104 U/L vs. 42 U/L, p < 0.001). 
Nonetheless, when recipients in the two groups (with donors with and without cardiac arrest) 
were compared, levels of serum AST on days 5 and 7 and levels of peak serum AST were similar 
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between groups. The two groups also had comparable graft survival at 6 months (87% vs. 88%) 
[18]. 
 
In LDLT, using a graft one third the size of a whole liver relies much on a short CIT. This policy is 
also adopted for DDLT at an LDLT center where CIT is slightly longer than 6 hours (median 386 
min, range 242-896 min) [19]. When a liver graft from a brain-dead heart-beating deceased 
donor recovered from cardiac arrest is used, the duration of down time and thus the WIT must 
be carefully monitored. A liver graft procured from a non-heart-beating donor has a higher 
chance of primary non-function [20] and is more prone to diffuse ischemic biliary injury [21]. 
Taking this to the extreme is a model of extracorporeal membrane oxygenation (ECMO) in 
donors with cardiac arrest with failed resuscitation. Organs obtained from donations after 
cardiac arrest are subjected to prolonged WIT. In a Spanish study of ECMO, donors with cardiac 
arrest were placed on the ECMO circuit. Recipient survival and graft survival at one year were 
82% and 70% respectively [22]. 
 
As Hoyer et al. [9] pointed out, selection of donors in their study was careful and not in a 
random manner. The donors with cardiac arrest were significantly younger, and their donated 
livers were in status 1A (28% vs. 17.7%, p = 0.028). Liver grafts procured from donors with 
cardiac arrest are often rejected by centers and used as rescue grafts for patients in dire 
emergency of liver failure. Marginal liver grafts are not transplanted to good-risk patients with 
low Model of End-stage Liver Disease (MELD) scores but to patients who are more ill. Similar 
experience was reported by the aforesaid French study [18]. Schaubel et al. [23] showed that 
pairing of marginal liver grafts with patients with low MELD scores failed to maximize survival 
benefit and may deny life-saving livers to patients with high MELD scores who have a high risk 
of death without transplantation. This is the day-in day-out experience of LDLT in the high-
urgency situation in Asia [24]. 
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What has not been discussed is the continuous assessment of potential liver donors’ 
resuscitation and liver function recovery. Donor management aims for near normal physiology 
of potential donors. After restoration of circulation after cardiac arrest, liver function can be 
assessed by biochemical and clotting profiles. Potential donors showing signs of progressive 
liver or multi-organ failure should be rejected. 
 
While there are factors conducive to graft failure after transplantation (Table 1), the weight 
carried by each one of these has yet been determined. A marginal graft would have a better 
chance of survival only if it is transplanted to an otherwise healthy patient with liver failure. At 
which point the transplant becomes futile is difficult to determine. In places where deceased 
donor liver grafts are scarce and LDLT is not feasible for various reasons, a very low graft 
survival is beneficial enough to the patients. Nevertheless, on a societal level, such a marginal 
graft could have a much higher chance of survival if it is transplanted to a less ill patient. While 
graft condition and the severity of illness of the patient cannot be changed, optimization of the 
liver graft by resuscitation of the donor helps to maximize the chance of success, in terms of 
graft survival as well as recipient survival. A short CIT, prompt graft recovery from donors, and 
meticulous graft implantation all count. 
 
Table 1. Factors adversely affecting graft survival 
Donor age > 60 years [1, 2, 25] 
Graft size Split or partial liver [1] 
Ischemia 
Donation after cardiac arrest [1] 
CIT > 10 hr [2, 19, 25] 
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WIT > 40 min [2] 
Parenchymal Fatty liver [19] 
Biochemical Serum sodium [25] 
Stature 
Weight [25] 
Less height [1] 
Body mass index [3] 
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